Aspen seeking registration of weight-loss drug
Used as a diabetes medication, tirzepatide cannot be promoted as an aid to weight loss without getting approval
24 December 2024 - 11:27
JSE-listed pharmaceutical company Aspen has applied to the medicines regulator for the registration of the drug tirzepatide — used to treat type 2 diabetes — as a weight loss medication. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
There’s never been a more important time to support independent media.
From World War 1 to present-day cosmopolitan South Africa and beyond, the Sunday Times has been a pillar in covering the stories that matter to you.
For just R80 you can become a premium member (digital access) and support a publication that has played an important political and social role in South Africa for over a century of Sundays. You can cancel anytime.
Already subscribed? Sign in below.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.